Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Both Diane 35 combinations effectively and safely reduce hirsutism and acne, with potential for better results if treatment extends beyond 12 months.

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Finasteride may reduce prostate cancer risk.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Upadacitinib may effectively treat resistant lichen planopilaris.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Dutasteride is approved to help manage prostate enlargement.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Minoxidil protects heart and improves recovery.

A new method accurately measures minoxidil and aminexil in drugs.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Certain herbal compounds might help prevent hair loss in menopausal women by activating Vitamin D receptors.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

Ajuga reptans L. extracts have strong antioxidant, anti-inflammatory, liver-protective, antimicrobial, and wound-healing properties.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Compound 4 is a promising treatment for hair loss with low toxicity.

The optimized formula promotes significant hair growth and could be a viable hair loss treatment.